Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

Study of the Safety, Tolerability and Efficacy of BTX 1204 in Patients With Moderate Atopic Dermatitis

ClinicalTrials.gov ID: NCT03824405

Public ClinicalTrials.gov record NCT03824405. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 27, 2026, 11:50 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Double-Blind, Vehicle-Controlled Study of the Safety, Tolerability and Efficacy of BTX 1204 in Patients With Moderate Atopic Dermatitis

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This is a randomized, double-blind, vehicle-controlled, Phase 2 study in subjects with moderate AD.

Study identification

NCT ID
NCT03824405
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Botanix Pharmaceuticals
Industry
Enrollment
200 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
12 Years to 70 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Feb 4, 2019 (Actual)
Primary completion
Jan 27, 2020 (Actual)
Completion
Mar 4, 2020 (Actual)
Last update posted
Oct 25, 2022

2019 – 2020

United States locations

U.S. sites
19
U.S. states
11
U.S. cities
19
Facility City State ZIP Site status
Applied Research Center of Arkansas Inc. Little Rock Arkansas 72212 —
T. Joseph Raoff MD Inc. / Encino Research Center Encino California 91436 —
Center for Dermatology Clinical Research Fremont California 94538 —
Dermatology Specialist Inc. - Murrieta Murrieta California 92562 —
Rady Childern's Hospital - San Diego San Diego California 92123 —
Clinical Science Institute Santa Monica California 90404 —
Precision Clinical Research Davie Florida 33328 —
Troy Sullivan North Miami Beach Florida 33162 —
DS Research Louisville Kentucky 40241 —
Delright Research New Orleans Louisiana 70115 —
Medisearch Clinical Trails Saint Joseph Missouri 64506 —
Washington Univerisy in St. Louis St Louis Missouri 63141 —
JDR Dermatology Research LLC Las Vegas Nevada 89148 —
The Acne Treatment and Research Center Morristown New Jersey 07960 —
Aventiv Research Inc - Dublin Dublin Ohio 43016 —
Greenville Dermatology, LLC Greenville South Carolina 29607 —
Dermresearch Inc Austin Texas 78759 —
J&S Studies Inc. College Station Texas 77845 —
The Center for Skin Research at Suzanne Bruce & Associates Dermatology Houston Texas 77056 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 12 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT03824405, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Oct 25, 2022 · Synced Oct 27, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT03824405 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →